does tirzepatide cause kidney issues Associated with Lower Risk of Heart and Damage Compared to Dulaglutide in Patients with Type 2 Diabetes and Cardiovascular Disease Diabetic cardiorenal injury and preventive

These side effects may go away during treatment as your body adjusts to the medicine

Adverse Reactions in Patients for Weight Reduction and Long-Term Maintenance Pool of Placebo-Controlled Weight Reduction Trials in Adults with Obesity or Overweight, with or without Type 2 Diabetes (Study 1 and Study 2) ZEPBOUND was evaluated for safety in a pool of two randomized, double-blind, placebo-controlled trials that included 2,519 adult patients with obesity or overweight treated with ZEPBOUND for up to 72 weeks and a 4-week off drug follow-up period (Study 1 and Study 2) [see Clinical Studies (14.1)]

Patients experiencing cyclic vomiting syndrome often report abdominal pain, inability to tolerate food or liquids, dizziness, fatigue, and metabolic complications associated with prolonged vomiting

The higher the dose, the more the weight loss

You'll also benefit from ongoing support with your provider